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Background: Terpenoids (isoprenoids) have numerous applications in flavors, fragrances, drugs and biofuels. The
number of microbially produced terpenoids is increasing as new biosynthetic pathways are being elucidated.
However, efforts to improve terpenoid production in yeast have mostly taken advantage of existing knowledge of
the sterol biosynthetic pathway, while many additional factors may affect the output of the engineered system.
Results: Aiming to develop a yeast strain that can support high titers of sclareol, a diterpene of great importance
for the perfume industry, we sought to identify gene deletions that improved carotenoid, and thus potentially
sclareol, production. Using a carotenogenic screen, the best 100 deletion mutants, out of 4,700 mutant strains, were
selected to create a subset for further analysis. To identify combinations of deletions that cooperate to further
boost production, iterative carotenogenic screens were applied, and each time the top performing gene deletions
were further ranked according to the number of genetic and physical interactions known for each specific gene.
The gene selected in each round was deleted and the resulting strain was employed in a new round of selection.
This approach led to the development of an EG60 derived haploid strain combining six deletions (rox1, dos2,
yer134c, vba5, ynr063w and ygr259c) and exhibiting a 40-fold increase in carotenoid and 12-fold increase in sclareol
titers, reaching 750 mg/L sclareol in shake flask cultivation.
Conclusion: Using an iterative approach, we identified novel combinations of yeast gene deletions that improve
carotenoid and sclareol production titers without compromising strain growth and viability. Most of the identified
deletions have not previously been implicated in sterol pathway control. Applying the same approach using a
different starting point could yield alternative sets of deletions with similar or improved outcome.
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Terpenoids (isoprenoids) are an important class of sec-
ondary metabolites contributing more than 70,000 com-
pounds to the rich chemical diversity of natural product
structures (The Dictionary of Natural Products Online:
http://dnp.chemnetbase.com/intro) [1]. Many terpenoids
possess pharmaceutical properties and are currently used
in clinical practice. Among them are taxol, a diterpene
from yew, which has successfully been established as a* Correspondence: antoniosmakris@yahoo.gr
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unless otherwise stated.major antineoplastic agent, and artemisinin, a sesquiter-
pene lactone, which is an effective antimalarial agent
[2-7]. Recently, attention has focused on microbially
produced terpenes as biofuels [8-12]. In addition, several
terpenes have attracted the interest of the flavour and
fragrance industry. Such examples include (+)-nootka-
tone, an oxidized sesquiterpene extracted from grape-
fruit [13], santalols, the main components of sandalwood
essential oil [14], and sclareol (Figure 1), an industrially
important diterpene precursor of a sustainable alterna-
tive to ambergris [15,16]. Most of commercially pro-
duced sclareol is derived by extraction from cultivated
Salvia sclarea. The sclareol biosynthetic pathway hashis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Pathway describing sclareol and carotenoid biosynthesis in yeast. Erg20p catalyzes the formation of C15 farnesyl pyrophosphate molecules
(FPP) for isoprenoid and sterol biosynthesis. A variant (F96C) enzyme was previously engineered to catalyze geranylgeranyl pyrophosphate synthesis
(GGPP). Fusion of ERG20 (F96C) to the Cistus creticus 8-hydroxy copalyl diphosphate synthase (CcCLS) generates 8-OH-CPP, which in turn is converted
to sclareol either through spontaneous hydrolysis in the acidified culture medium or enzymatically by the Salvia sclarea sclareol synthase (SsSCLS). In
carotenoid biosynthesis the inserted carotenogenic pathway cassette of X. dendrorhous expresses the the GGPP synthase (encoded by the crtE gene),
the bifunctional enzyme phytoene synthase/lycopene cyclase (encoded by the crtYB gene) and phytoene desaturase (encoded by the crtI gene).
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S. cerevisiae [15,16].
Terpenoids are biosynthesized from two C5 precur-
sors, isopentenyl diphosphate (IPP) and dimethylallyldiphosphate (DMAPP) [17]. In yeast and mammals, IPP
originates from acetyl-CoA through the intermediate
mevalonic acid (MVA). IPP then gives rise to the higher
order building blocks, geranyl pyrophosphate (GPP;
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nyl pyrophosphate (GGPP; C20) through the action of
prenyltransferases [17]. In yeast, most of the pathway
output in the form of FPP is utilized for the biosynthesis
of sterols. The terpene hydrocarbon scaffolds are gener-
ated by the action of mono-, sesqui-, and diterpene
synthases that catalyze multistep reactions using GPP,
FPP or GGPP as substrates, respectively. Although S.
cerevisiae does not produce terpenoids, expression of
plant derived terpene synthases in yeast cells revealed
that it was possible for the enzymes to utilize the en-
dogenous substrates (GPP, FPP, GGPP) and produce a
range of terpenoid compounds [4,18]. The number of
terpenoids produced in heterologous systems is continu-
ously growing as more pathways become elucidated and
new genes are cloned and characterized. In parallel to
the gene discovery effort to identify and characterize en-
zymes producing chemicals of value, there has been a
continuous effort to generate high producing yeast
strains. Approaches to improve terpenoid production in
yeast have mostly focused on existing knowledge of the
sterol biosynthetic pathway with considerable success
[4,19,20] (reviewed in [21]). Some key interventions in
this direction include a) the deregulation of HMG-CoA
reductase (HMGR) by truncation of the regulatory trans-
membrane domain [22] or point mutations (K6R) in
HMG2 which render the enzyme resistant to ubiquitina-
tion [23,24] and b) the suppression of the squalene syn-
thase gene (ERG9), which controls the major isoprenoid
substrate draining route, that of ergosterol synthesis
[4,19,24,25]. However, the magnitude and complexity of
genetic interactions identified in yeast cells [26], suggest
that the output of a biosynthetic pathway may also be af-
fected by a large number of seemingly unrelated factors.
Taking advantage of genetic interaction data, a set of
heterozygous gene deletions that increased endogenous
hmgp levels and consequently improved sesquiterpene
biosynthesis was identified [27].
Quick and inexpensive selection methods have been
invaluable tools for strain improvement, as they can dra-
matically expedite the process and identify novel targets
of intervention. Carotenoid biosynthesis has been a goal
in itself and a powerful tool for strain improvement
[28-32]. Carotenoid formation in yeast utilizes endogen-
ously produced FPP substrate through the activity of a
heterologous GGPP synthase, a phytoene synthase, a
phytoene desaturase, and a lycopene cyclase (Figure 1)
[31,32]. The intensity of the color produced is linked to
substrate availability, and allows for rapid screening. Re-
cently Özaydin et al. [29] employed a carotenoid screen
on the yeast deletion strain library to identify mutations
that can enhance sesquiterpene biosynthesis in yeast.
The antioxidant capacity of carotenoids has also been
utilized to evolve yeast strains producing high levels ofcarotenoids using H2O2 as the prooxidant pressure [30].
A carotenoid screen has also been applied for the selec-
tion of yeast Erg20p variants capable of catalyzing all
three IPP additions from DMAPP to GGPP, alleviating a
major bottleneck for diterpenoid biosynthesis in yeast
cells, the low availability of GGPP substrate [33].
In the current study we established and applied a het-
erozygous deletion screen to identify genes that restrict
carotenoid, and potentially diterpene, productivity. We
prioritized genes for analysis, on the basis of the lower
number of genetic and physical interactions known, to
minimize the possibility of the homozygous deletion
causing undesirable effects in other cellular pathways.
Through an iterative application of this approach, a set
of six deletions were identified which led to a 12-fold
increase in sclareol titer (750 mg/L) over wild type cells,
without obvious effects on yeast robustness and viability.
Results
Identification of a working subset of gene deletions that
enhance carotenoid production
A heterozygous gene deletion in S. cerevisiae typically re-
sults in a 50% decrease in the corresponding protein levels
[34]. This allows for the development of a stringent screen
that monitors the result of protein depletion in a specific
phenotype. By contrast to a haploid or homozygous dip-
loid deletion screen, this approach does not exclude genes
whose complete inactivation causes severe growth impedi-
ments, and which could eventually be downregulated
using more elaborate approaches (e.g. ERG9 downregula-
tion for isoprenoid production – reviewed in Kampranis
and Makris [21]). To identify heterozygous gene deletions
in yeast that support increased carotenoid, and conse-
quently diterpene, production, we set out to develop a sys-
tem to screen the collection of yeast viable deletion strains
using a carotenogenic screen. To this end, we developed a
haploid yeast strain that expresses the GGPP synthase
(crtE), the phytoene synthase/lycopene cyclase (crtYB)
and the phytoene desaturase (crtI) genes from Xantho-
phyllomyces dendrorhous and, as a result, produces carot-
enoids [32]. To maintain a fixed gene copy number and
improve reproducibility of carotenoid production, these
genes were stably integrated into the genome. This strain
was created by transforming EG60 wild type Mat α hap-
loid cells with the linearized vector YEplac195-YB/I/E [32]
and selecting transformed cells on glucose CM media
lacking uracil. Cells from transformed colonies were sub-
sequently maintained in media without selection. To
develop a heterozygous deletion screen, a single colony
with moderate and stable carotenoid coloration was
grown and crossed to the whole library of 4,700 gene dele-
tion mutants in BY4741 (MATa, his3Δ1, leu2Δ0, met15Δ0,
ura3Δ0) genetic background (Research Genetics) and to
BY4741 parental cells as a control. Cells were placed on
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the diploid cells (uracil complementation originates from
the YEplac195-YB/I/E vector and tryptophan complemen-
tation from the BY4741 genetic background). Visual
inspection of the crosses revealed a palette of red color
intensities. In some crosses carotenoid formation was
abolished completely, most others were similar in color-
ation to the control, and a small group contained a high
percentage of intensely red colored colonies (Figure 2).
This group, which consisted of approximately one hundred
genes, was selected as a subset for further characterization
(Additional file 1: Table S1). Interestingly, eight of the
selected genes (dos2, lcl1, erg3, ipt1, pth1, skn1, sur1 and
yor292c) were also identified in a screen for miconazole re-
sistance [35]. Miconazole interacts with 14α-demethylase,
a cytochrome P450 enzyme necessary to convert lanosterol
to ergosterol, and the mutants presumably act either by
boosting lanosterol production, or by alleviating the effect
of ergosterol depletion on yeast membrane function. The
selected group was analyzed for enrichment of biological
processes by querying the Gene Ontology (GO) experi-
mental dataset for S. cerevisiae (http://geneontology.org/)
[36]. “Sphingolipid biosynthesis and metabolism” and “cell
wall” were top among the enriched terms found, sug-
gesting a role of these deletions on cell membrane
function (Table 1).Figure 2 Screening assay to identify heterozygous deletions in yeast which
chromosomally integrated cassette YEplac195-YB/I/E expressing the GGPP s
phytoene desaturase (crtI) genes from Xanthophyllomyces dendrorhous wer
selected and plated. Colonies exhibiting higher percentage of intensely redTo independently validate the contribution of the
selected deletions in carotenoid productivity, we also
tested the corresponding haploid deletion strains carry-
ing the YEplac195-YB/I/E plasmid episomally. At the
time this work was in process, Ӧzaydin and co-workers
published results from a similar screen which identified
rox1, a heme-dependent transcriptional repressor, as an
important deletion affecting carotenoid and sesquiterpe-
noid production [29]. Although the rox1/ROX1 diploid
was not identified as a high carotene producer in our
screen, we chose to include rox1 in our subset. The
majority of the deletion strains tested exhibited higher
carotenoid yields than control wild type BY4741 cells
(Figure 3). The set of the best performing deletions is
shown in Figure 3. A subset of 9 deletions that includes
rox1 (dos2, yor292c, rps19b, snx3, stm1, exg1, fbp26,
mrpl24 and rox1) stood out with yields >400 μg caroten-
oids/g dry cell weight (DCW) (Figure 3).
Combining deletions to increase carotenoid and sclareol
productivity
Imbalances in the mevalonate biosynthetic pathway have
been shown to cause suppression of terpenoid biosyn-
thesis. The effects of higher levels of hmgp depend on
the strains’ genetic background [24]. To test whether dele-
tions can be combined to obtain additional productivityenhance carotenoid biosynthesis. Mat a yeast cells harbouring a
ynthase (crtE), the phytoene synthase/lycopene cyclase (crtYB) and the
e mated with the Mat α yeast deletion strain library. Diploid cells were
colonies were selected out for characterization.
Table 1 List of Gene Ontology enriched annotated terms for the selected set of genes
Term Background frequency Sample frequency Expected +/− P-value
sphingolipid biosynthetic process (GO:0030148) 22 4 3.313e-01 + 5.855e-03
sphingolipid metabolic process (GO:0006665) 32 4 4.818e-01 + 2.520e-02
carbohydrate derivative metabolic process (GO:1901135) 214 10 3.289e + 00 + 2.760e-02
regulation of transcription factor import into nucleus (GO:0042990) 4 2 6.147e-02 + 2.875e-02
cell wall biogenesis (GO:0042546) 90 6 1.383e + 00 + 4.409e-02
inositolphosphoceramide metabolic process (GO:0006673) 6 2 9.221e-02 + 6.341e-02
peroxisome degradation (GO:0030242) 22 3 3.381e-01 + 7.830e-02
lipid biosynthetic process (GO:0008610) 136 7 2.090e + 00 + 8.220e-02
polysaccharide metabolic process (GO:0005976) 45 4 6.916e-01 + 8.473e-02
membrane lipid biosynthetic process (GO:0046467) 47 4 7.223e-01 + 9.851e-02
Trikka et al. Microbial Cell Factories  (2015) 14:60 Page 5 of 19increases, we proceeded to generate a rox1 strain in EG60
background, AM228 (Table 2), and cross it to the selected
library subset. After transformation with the YEplac195-
YB/I/E plasmid (AM228-1) and mating with the selected
subset of strains, a range of color intensities was observed,
ranging from very light orange to reddish. As expected,
heterozygocity of rox1/ROX1 produced limited amounts
of carotenoids, whereas rox1/rox1 produced strong color
(Figure 4A). Three double heterozygous deletion mutants
rox1/dos2, rox1/sfk1 and rox1/yer134c produced veryFigure 3 Carotenoid production in selected haploid deletion strains. The s
E plasmid. Cells were grown in 50 ml glucose CM-uracil for 5 days. Caroten
the highest producing deletion and rox1, a previously identified enhancer o
blue color.strong coloration and high carotenoid yields (Figure 4A
and B). An additional second set which was the most nu-
merous in the visual screen exhibited a lower, but evident,
increase in coloration over the control rox1/ROX1 strain.
From the high yielding group of genes, we chose to
proceed with dos2, as it was consistently picked up in all
screens so far. DOS2 encodes a cytoplasmic protein of
unknown function, whose null mutant exhibits increased
competitive fitness and resistance to miconazole [35]. To
inactivate DOS2 in the rox1 haploid strain AM228, weelected haploid deletion strains were transformed with YEplac195-YB/I/
oids were extracted from liquid cultures and quantified. In green, dos2,
f carotenoid biosynthesis. The wild type BY4741 parental is shown in
Table 2 List of developed yeast strains
Strain Genotype Plasmid description Source
BY4741 MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0. Research
Genetics
EG60 MATα, ura3, trp1, his3. Erica
Golemis
EG60-2 MATα, ura3, trp1, his3. YEplac195-YB/I/E (PTDH3-crtYB-tCYC1, PTDH3-crtI-tCYC1,
PTDH3-crtE-tCYC1, URA3, 2 μ)
This study
EG60-3 MATα, trp1, his3 PTDH3-crtYB-tCYC1, PTDH3-crtI-tCYC1,
PTDH3-crtE-tCYC1, URA3
This study
EG60-4 MATα, ura3, trp1, his3. pUTDH/CLS-ERG20 (F96C) (PTDH3-CcCLS-ERG20 (F96C)-tCYC1,
2 μ, URA3)
This study
EG60-5 MATα, ura3, trp1, his3. pUTDH3/HMG1-TM-EYFP, 2 μ PTDH3-HMG1-TM-EYFP URA3 This study
EG60-6 MATα, ura3, trp1, his3. pUTDH3/Sf126-EYFP, 2 μ PTDH3-Sf126-EYFP URA3 This study
AM228 MATα his3, ura3, trp1, rox1 derived from EG60 This study
ΑΜ228-1 MATα his3, ura3, trp1, rox1 derived from EG60 YEplac195-YB/I/E (PTDH3-crtYB-tCYC1, PTDH3-crtI-tCYC1,
PTDH3-crtE-tCYC1, URA3, 2 μ)
This study
ΑΜ228-2 MATα his3, ura3, trp1, rox1 derived from EG60 pUTDH/CLS-ERG20 (F96C) (PTDH3-CcCLS-ERG20 (F96C)-tCYC1,
2 μ, URA3)
This study
AM229 MATα his3, ura3, trp1, rox1, dos2 derived from
AM228
This study
AM229-1 MATα his3, ura3, trp1, rox1, dos2 derived from
AM228
YEplac195-YB/I/E (PTDH3-crtYB-tCYC1, PTDH3-crtI-tCYC1,
PTDH3-crtE-tCYC1, URA3, 2 μ)
This study
AM229-2 MATα his3, ura3, trp1, rox1, dos2 derived from
AM228
pUTDH/CLS-ERG20 (F96C) (PTDH3-CcCLS-ERG20 (F96C)-tCYC1,
2 μ, URA3)
This study
AM230 MATα his3, ura3, trp1, rox1, dos2, yer134c derived
from AM229
This study
AM230-1 MATα his3, ura3, trp1, rox1, dos2, yer134c derived
from AM229
YEplac195-YB/I/E (PTDH3-crtYB-tCYC1, PTDH3-crtI-tCYC1,
PTDH3-crtE-tCYC1, URA3, 2 μ)
This study
AM230-2 MATα his3, ura3, trp1, rox1, dos2, yer134c derived
from AM229
pUTDH/CLS-ERG20 (F96C) (PTDH3-CcCLS-ERG20
(F96C)-tCYC1, 2 μ, URA3)
This study
AM231 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5
derived from AM230
This study
AM231-1 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5
derived from AM230
YEplac195-YB/I/E (PTDH3-crtYB-tCYC1, PTDH3-crtI-tCYC1,
PTDH3-crtE-tCYC1, URA3, 2 μ)
This study
AM231-2 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5
derived from AM230
pUTDH/CLS-ERG20 (F96C) (PTDH3-CcCLS-ERG20 (F96C)-tCYC1,
2 μ, URA3)
This study
AM233 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5,
ynr063w derived from AM231
This study
AM233-1 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5,
ynr063w derived from AM231
YEplac195-YB/I/E (PTDH3-crtYB-tCYC1, PTDH3-crtI-tCYC1,
PTDH3-crtE-tCYC1, URA3, 2 μ)
This study
AM233-2 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5,
ynr063w derived from AM231
pUTDH/CLS-ERG20 (F96C) (PTDH3-CcCLS-ERG20 (F96C)-tCYC1,
2 μ, URA3)
This study
AM238 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5,
ynr063w, ygr259c derived from AM233
This study
AM238-1 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5,
ynr063w, ygr259c derived from AM233
YEplac195-YB/I/E (PTDH3-crtYB-tCYC1, PTDH3-crtI-tCYC1,
PTDH3-crtE-tCYC1, URA3, 2 μ)
This study
AM238-2 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5,
ynr063w, ygr259c derived from AM233
pUTDH/CLS-ERG20 (F96C) (PTDH3-CcCLS-ERG20 (F96C)-tCYC1,
2 μ, URA3)
This study
AM238-3 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5,
ynr063w, ygr259c derived from AM233
pUTDH/CLS-ERG20 (F96C) (PTDH3-CcCLS-ERG20 (F96C)-tCYC1,
2 μ, URA3); pHTDH/CD-HMG2 (PTDH3-CD-HMG2-tCYC1,
2 μ, HIS3; pWTDH/SCLSmat (PTDH3-SCLS-tCYC1, 2 μ TRP1
This study
AM238-4 MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5,
ynr063w, ygr259c derived from AM233
pUTDH3/HMG1-TM-EYFP, 2 μ PTDH3-HMG1-TM-EYFP URA3 This study
AM238-5 pUTDH3/Sf126-EYFP, 2 μ PTDH3-Sf126-EYFP URA3 This study
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Table 2 List of developed yeast strains (Continued)
MATα his3, ura3, trp1, rox1, dos2, yer134c, vba5,
ynr063w, ygr259c derived from AM233
AM109-1 MATa/α, GALp-(K6R)HMG2::HOX2, ura3, his3, trp1,
PTDH3-HMG2(K6R)X2-::leu2, PTDH3-HMG2(K6R)::HO1,
ERG9/erg9, UBC7/ubc7, ssm4/SSM4, pho86/PHO86,
derived from AM102
pUTDH3/HMG1-TM-EYFP, 2 μ PTDH3-HMG1-TM-EYFP URA3 This study
AM109-2 MATa/α, GALp-(K6R)HMG2::HOX2, ura3, his3, trp1,
PTDH3-HMG2(K6R)X2-::leu2, PTDH3-HMG2(K6R)::HO1,
ERG9/erg9, UBC7/ubc7, ssm4/SSM4, pho86/PHO86,
derived from AM102
pUTDH/CLS-ERG20 (F96C) (PTDH3-CcCLS-ERG20 (F96C)-tCYC1,
2 μ, URA3)
This study
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flanked by DOS2 sequences 5’ and 3’ of the ORF. Integra-
tion was validated and the new strain was named AM229
(rox1, dos2). Visual inspection of AM229 cells expressing
crtYB/I/E showed increased carotenoid production.
AM229 was crossed to the library subset and tested
for color. YER134c, identified as a magnesium-
dependent acid phosphatase, whose deletion was again
among the higher producers. Combined with the low
number of genetic (GI = 8) and physical (PI = 6) interac-
tions known, (compiled by Saccharomyces Genome
Database http://www.yeastgenome.org/ and curated by
Biogrid http://thebiogrid.org/ ), these directed us to tar-
get this gene for deletion. The triple deletion strain,
AM230 (rox1, dos2, yer134c), did not exhibit any growth
impediments. In the presence of the YEplac195-YB/I/E
plasmid, coloration was increased compared to the par-
ent strain.
To identify additional candidates for disruption, the
AM230 strain transformed with the YEplac195-YB/I/E
plasmid (AM230-1), mated with the selected library sub-
set, and diploid AM230 X Library cells were selected as
above. Two heterozygous deletion strains (vba5/VBA5
and yor292c/YOR292c) stood out (Figure 5A). VBA5 is a
vacuolar and plasma membrane amino acid transporter
whose deletion increased competitive fitness and replica-
tive lifespan [37]. YOR292c is a non-essential vacuolar
membrane protein whose deletion led to miconazole
resistance [35]. Both have been reported to have a small
number of genetic interactions, (GI = 1) and (GI = 2),
respectively. We chose to inactivate vba5 generating
strain AM231. The strain was subsequently transformed
with the YEplac195-YB/I/E plasmid (AM231-1) and mated
once more to the deletion set. Twelve strains yielded sig-
nificantly higher levels of carotenoids (Figure 5B). From
this set, we chose to proceed with YNR063w, a putative
zinc-cluster protein, being the gene with the fewest
interactors (GI = 9) by a long margin from the first four
(slt2 (GI = 554); npr3 (GI = 91); ntc20 (GI = 19); stm1
(GI = 71)), and whose null mutation leads to increased
competitive fitness. The YNR063w gene was disrupted
giving rise to strain AM233 (rox1, dos2, yer134c, vba5,
ynr063w). As seen in Figure 6A and B, in the processdescribed there is a sequential increase in yields, reach-
ing 1.8 mg carotenoids/g DCW in the case of AM233.
An additional round of screening identified YGR259c,
a small orf which fully overlaps with the larger TNA1/
YGR260w orf. TNA1 is a nicotinic acid plasma mem-
brane permease that is found to physically associate with
numerous proteins involved in sterol, fatty acid and
sphingolipid metabolism [38]. YGR259c was deleted,
generating strain AM238. The strain was evaluated for
carotenoid production but did not show any further
increase compared to AM233 (data not shown). At this
point it was deemed appropriate to test for sclareol
productivity. The base strain EG60 and all the tandem
deletion strains were transformed with plasmid express-
ing a fusion between the Cistus creticus 8-hydroxy-
copalyl diphosphate synthase (CcCLS) and a mutant
form of Erg20p which is capable of producing GGPP
[39]. A sequential increase in sclareol yields is observed
in each successive sequential strain reaching on average
26 mg/L in AM238 cells compared to 6 mg/L in wt
EG60 cells (Figure 7).
Analysis of the effect of the selected mutations on the
sterol biosynthetic pathway
In a previous effort to develop optimal strains for sesqui-
terpene production by disrupting single alleles of HMG1
and HMG2 genetic interactors, the developed strains ex-
hibited increased stability of Hmg1p, suggesting a func-
tion for the selected deletions [27]. To assess whether
the strains developed here also exhibit improved Hmg1p
stability, we transformed EG60, AM228, AM229, AM230,
AM238, and a positive control, AM109 [27], strains with
plasmid pUTDH/HMG1-TM-EYFP. This plasmid ex-
presses a fusion of the transmembrane domain (TM) of
Hmg1p to EYFP [27]. Fifty thousand cells from each cul-
ture grown in triplicate were measured by flow cytometry
and the mean fluorescence intensity was estimated.
Hmg1p-TM-EYFP fluorescence initially decreased some-
what after the rox1 deletion but recovered to wild type
levels in AM238 cells. In contrast, fluorescence increased
substantially in AM109 cells (Figure 8A), suggesting that
the carotenoid/diterpene and sclareol increase observed in
the engineered strains is not due to Hmgp stabilization.
Figure 4 (See legend on next page.)
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Figure 4 Combined heterozygous deletions can cooperate to enhance carotenoid yields. (A) Selected representative double heterozygous
deletion strains expressing crtYB/crtI/crtE. L to R. 1st row: rox1/rox1 positive control; rox1/ROX1 All test strains bellow are heterozygous mutants for
rox1 and the additional deletion tested; 2nd row: ipt1; dos2; cdc40; mef1; 3rd row: atg27; tpp1; rps14b; rps19b; 4th row: ist1; ykl053; yer134c; sfk1, (Β)
Quantification of extracted carotenoids from three independent cultures of the diploid double heterozygous deletion strains grown in 50 ml
glucose CM-U, W. The diploid homozygous rox1/rox1 is shown in red.
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8OH-CPP and subsequently to sclareol, can be released
to the medium and hydrolyzed to farnesol (FOH) and
nerolidol (NOH) from FPP, and geranyllinalool (GLOH)
and geranylgeraniol (GGOH) from GGPP [39]. These me-
tabolites were quantified in all engineered strains. Strains
carrying empty vector showed a small increase in NOH+
FOH levels in each successive modification (Figure 8B).
Expression of CLS-ERG20 (F96C) fusion led to a substan-
tial increase in NOH+ FOH levels subsequent to the
second deletion (AM229 rox1 dos2, AM230 rox1 dos2
yer134c, AM231 rox1 dos2 yer134c vba5, AM233 rox1
dos2 yer134c vba5 ynr063w, AM238 rox1 dos2 yer134c
vba5 ynr063w ygr259c ) (Figure 8B). The released sesqui-
terpenols in AM238 cells expressing CLS-ERG20 (F96C)
were at 4-fold higher levels than the corresponding wild
type cells. No GLOH+GGOH was detected in all strains
carrying empty vector (not shown). Among the strains ex-
pressing CLS-ERG20 (F96C) increasing levels of GLOH +
GGOH was subsequent to the second deletion (Figure 9C).
Sclareol synthase (SCLS) a class I diterpene synthase
(diTPS), previously isolated from Salvia sclarea, converts
8OH-CPP to sclareol and manool [15]. Co-expression of
SCLS in wild type EG60 and AM238 cells reduced levels
of released GLOH+GGOH, indicating that the enzymatic
conversion can be more efficient than spontaneous hy-
drolysis (Figure 9D). NOH + FOH levels were not reduced
to a great extent (data not shown).
In the sterol biosynthetic pathway, FPP gives rise to
squalene, which, in turn, is converted through a series of
steps to ergosterol. The amounts of ergosterol and squa-
lene produced by strains EG60, AM228, AM229,
AM230, AM238 and AM109 were quantified. Deletion
of rox1 in strain AM228 led to ergosterol increase. This
is not surprising a ROX1 is a known suppressor of the
ergosterol biosynthetic pathway [40]. This increase is
maintained in the successive engineered strains (AM229,
AM230, AM238), suggesting a plateau in ergosterol
levels (Figure 9A). Upon overexpression of the CLS-
ERG20 (F96C) fusion in EG60, AM229 and AM238 cells,
ergosterol levels in the latter two increased substantially,
reaching an average of 10.6 mg/g ergosterol for AM238
cells (Figure 9B).
Excess lipids are stored intracellularly as lipid droplets,
ubiquitous organelles composed of a neutral lipid core
surrounded by a phospholipid monolayer. In yeast, lipid
particles consist of triacylglycerols (TGs) and sterylesters (SE) roughly in equal amounts. To assess whether
the observed changes in ergosterol levels are reflected in
the stored lipid contents, cells were stained with Nile
Red, a lipophilic dye accumulating in neutral lipid de-
posits. Strains EG60, AM228, AM229, AM230, AM231,
AM233, AM238 carrying either empty vector or ex-
pressing CLS-ERG20 (F96C) were grown to saturation
over a 5 day period and were stained with Nile Red. Dis-
tinct intracellular structures are evident by fluorescent
microscopy (Figure 10A). Fluorescence intensity was
quantified in 50.000 cells from each strain by flow
cytometry. Plot overlays of cell counts to fluorescence
intensity were generated (Figure 10B) and the mean
fluorescence intensities were calculated (Figure 10C).
Deletion of rox1 in AM228 cells resulted in fluorescence
increase which remained steady at subsequent perturba-
tions. Expression of CLS-ERG20 (F96C) led to increased
fluorescence subsequent to the third deletion (strains
AM230, AM231, AM233, and AM238). The Nile Red
results agree with the observed ergosterol increases in
AM238 cells expressing CLS-ERG20 (F96C) (Figure 9B)
and the NOH + FOH increased yields (Figure 8B). Over-
all, it appears that the initial genetic perturbations
(AM228, AM229, AM230, and AM231) lead to increases
in the mevalonate pathway biosynthesis, whereas for the
subsequent deletions (AM233, AM238) improvements
in yields are not due to increased substrate production.
Taking into consideration our previous results, it
appears that the sclareol conversion process could be
further optimized by co-expressing, the mature form of
sclareol synthase from Salvia sclarea (SCLS), and the cata-
lytic domain of HMG2 (CD-HMG2) which encodes for a
constitutively active 3-hydroxy-3-methyl-glutaryl-CoA re-
ductase, a key enzyme in the control of the mevalonate
pathway. Whereas wild type EG60 cells co-expressing the
above three genes produced only 62 mg/L, AM238 cells
co-expressing the same genes reached titres of 743 mg/L, a
12-fold increase (Figure 11A).
Wild type EG60 and AM238 strains co-expressing CLS-
ERG20 (F96C), CD-HMG2, and SCLS expectedly released
substantially higher NOH+ FOH due to the presence of
the CD-HMG2 (7.58 mg/L for EG60 and 5.86 mg/L for
AM238 strain). Released GLOH+GGOH averaged to
2.2 mg/L for EG60 and 1.86 mg/L for AM238, indicating
a higher proportion of substrates being converted to final
products in AM238 cells (Figure 11B). Ergosterol levels
were reduced by half in AM238 cells, averaging 5.4 mg/g
Figure 5 (See legend on next page.)
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Figure 5 Carotenoid quantification in 4- and 5- heterozygous deletion strains. (A) Strain AM230 (rox1, dos2, yer134c) expressing crtYB/crtI/crtE was
mated to the set of deletion strains, grown and carotenoids were extracted and quantified. The selected vba5 deletion is shown in green color.
Control 3-deletion heterozygous strain is shown in blue; (B) Strain AM231 (rox1, dos2, yer134c, vba5) expressing crtYB/crtI/crtE was mated to the
set of deletion strains as above. In green ynr063w selected for additional improvement. Control 4-deletion heterozygous strain is shown in blue.
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only (Figure 9B). At the same time squalene levels in-
creased substantially in both strains, which is attributed to
the effects of CD-HMG2 expression. Co-expression of
SCLS and CD-HMG2 led to substantial improvements in
substrate availability and utilization and targeting ERG9
could further reduce FPP flow towards sterol synthesis
and lead to additional sclareol yields.
Discussion
Aiming to develop a productive yeast platform for sclar-
eol production, we undertook a screen of deletions
strains suitable for diterpene biosynthesis. The carotenoid
screen has been successfully used in the past for discover-
ing yeast deletions which would improve sesquiterpenoidEG60   AM228  AM229  AM230  AM231    AM233
Figure 6 Carotenoid production of improved haploid strains. (A)
Color formation in yeast cultures due to carotenoids formed in
liquid cultures of two independent cultures of AM233 versus control
wild type BY4741 cells; (B) wild type EG60, AM228 (rox1), AM229
(rox1, dos2), AM230 (rox1, dos2, yer134c) and AM231 (rox1, dos2,
yer134c, vba5), AM233 (rox1, dos2, yer134c, vba5, ynr063w) expressing
crtYB/crtI/crtE were grown in independent triplicate cultures and
carotenoids were extracted and quantified. Tandem deletions lead
to substantial yield improvements.production [29]. We developed and applied an alternative
version of the screen which would enable us to identify
haploinsufficiencies which enhance carotenoid productiv-
ity (Figure 12). To avoid the issue of plasmid instability in
our screen which results in white colonies the YB/I/E clus-
ter was integrated into the genome. However, the hetero-
geneity of carotenogenesis remained despite cluster
integration. An alternative explanation could be that
GGPP formation causes feedback inhibition to compo-
nents of the ergosterol biosynthetic pathway [41]. This
screen enabled the selection of a set of approximately 100
candidate strains exhibiting improved carotenoid product-
ivity. The set of identified gene deletions did not overlap
with the corresponding ones from the Ozäydin et al.
screen. Deletion in ERG3 identified in the current screen
could be functionally equivalent to ERG24 deletion previ-
ously found, as both genes code for interacting enzymes
of the ergosterol biosynthetic pathway. The alternative
carotenogenic screen applied here requires a dominant
effect on a heterozygous background, as can be seen in
the case of ROX1 deletion (Figure 4. Most strains also
exhibited improvement in sclareol production. Iteration of
the carotenonogenic screen incorporating the previously
selected perturbations allowed stepwise improvement in
carotenoid yields. The successive compilations of deletions
during repetitions of the carotenoid screen, made evident
that the previous deletion genetic background altered the
performance of the newly introduced ones. Deletions
which perform well in a given genetic backgroundFigure 7 Sclareol titers in engineered yeast strains expressing CLS-
ERG20 (F96C). Wild type EG60, AM228, AM229, AM230, AM233 and
AM238 cells expressing CLS-ERG20 (F96C) were grown in 5 ml cultures
in a roller drum for 24 hours. Subsequently, 500 μl dodecane overlay was
added to the media and further incubated for 48 hours. The dodecane
phase was analyzed by GC-MS and sclareol was quantified by GC-FID.
Figure 8 Assessing the state of the mevalonate pathway in engineered strains. (A) The transmembrane domain (1–667) of HMG1 which is
regulated by proteolytic degradation was fused to EYFP and expressed by a stable promoter. The mean fluorescence from 50.000 cells per culture
in triplicate was measured by flow cytometry. Increased Hmgp stability does not play a role in observed strain improvements; (B) Excess FPP and
GGPP which is not converted by CLS to 8OH-CPP can be released in the medium and hydrolyzed to farnesol (FOH) and nerolidol (NOH) from FPP, and
geranyllinalool (GLOH) and geranylgeraniol (GGOH) from GGPP. These metabolites were quantified in the engineered strains. Cells carrying
empty vector show a small increase in NOH, FOH levels at each successive modification. Expression of CLS-ERG20 (F96C) leads a substantial increase
subsequent to the second genetic perturbation (AM229); (C) GLOH+ GGOH are increasing after the second perturbation; (D) co-expression of CLS-
ERG20 (F96C) with SCLS reduced the levels of released GLOH+ GGOH, as substrate is efficiently converted to sclareol.
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initial mild effect later show increased impact. This is not
surprising, as deletions affecting the same, or other co-
operating or competing pathways can reach different final
output readout. Imbalances caused by uneven effects on
the biosynthetic pathway can also lead to decreased prod-
uctivity. The iterative screen approach allows the identifi-
cation of perturbations for which no previous knowledge
of their involvement exists, and the compilation of com-
patible perturbations improving the final output.
In our carotenoid screen, eight of the deletions in the
set had been re-identified in a screen for resistance to
miconazole. The main mode of azole function is the
inhibition of ergosterol biosynthesis. Several of the mi-
conazole resistant deletion resistant mutants (IPT1,
SKN1, SUR1, ERG3) affected sphingolipid and ergosterol
biosynthesis, molecules enriched in lipid rafts [35].
Membrane rafts are thought to compartmentalize the
plasma membrane and play an important role in cell sig-
naling. It is plausible that signaling from lipid rafts mayrelay perceived membrane sterol levels to the regulatory
machinery. Interestingly, rox1 deletion which was identi-
fied in a previous carotenoid screen as inducer of caroten-
oid biosynthesis, also exhibited decreased susceptibility to
azole compounds. For miconazole specifically, the 50% In-
hibitory Concentration, IC50, increased by 2.5-fold on
average [42]. ROX1 deletion was found to result in in-
creased expression of most ERG biosynthetic genes. In
models of ergosterol pathway transcriptional control
ROX1 together with MOT3 is thought to repress ECM22
upon osmotic stress and exert a direct effect by binding
on several ERG promoters [40]. Still, knowledge is lacking
as to the signaling pathways regulating ergosterol homeo-
stasis. Presumably, some of the newly identified deletions
may play roles in such complex regulatory processes. Our
screening setup enabled us to match the line of deletions
which can act cooperatively and incrementally increase
the availability of substrate. DOS2 deletion was judged to
be a suitable combination with ROX1 inactivation. The
DOS2 gene (YDR068w) had also been identified in the
Figure 9 Increased ergosterol yield in engineered strains. (A) Ergosterol
and squalene quantification in strains EG60, AM228, AM229, AM230,
AM238 and AM109 cells; (B) Ergosterol and squalene quantification in
EG60, AM229, AM238 cells overexpressing CLS-ERG20 (F96C).
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highest levels of carotenoid formation, and as heterozy-
gous deletion with rox1, it exerted a similar effect. De-
siring to maintain the option of using the deletions in a
haploid or diploid heterozygous genetic background, we
selected the most peripheral among candidate genes,
trying to avoid compromising strain robustness.
YER134c, VBA5, YNR063w, YGR259c have not previ-
ously been associated with phenotypes which disrupt
important cell pathways.
Depending on the initial choice of perturbation, differ-
ent subsets of deletions yielding the same outcome could
likely be generated. When the corresponding null dele-
tions do not cause a significant growth impediment the
phenotypes observed in heterozygous background trans-
late equally well or better in haploid deletions. An itera-
tive carotenogenic screen could also be established in a
haploid genetic background based on a Synthetic Gen-
etic Array (SGA) approach [43], if additional selection
markers are used to compile a set of four perturbations.
The availability of endogenous GGPP is a major limit-
ing factor. Overexpression of the native BTS1 respon-
sible for catalysing GGPP formation would most likelynot be able to efficiently convert the FPP formed. It is
likely that in S. cerevisiae only low levels of GGPP are
required. Increased levels of the substrates FPP and
GGPP of the mevalonate pathway cause feedback inhib-
ition by destabilizing hmgp [41]. To minimize this effect,
we chose to overexpress a variant of ERG20 (F96C), cap-
able of synthesizing all three steps leading to GGPP, as
fusion to the 8OH-CPP synthase CLS [33,44]. Overex-
pression of CLS-ERG20 (F96C) likely siphons GGPP
towards 8OH-CPP and finally sclareol, preventing feed-
back inhibition. In the engineered strains expression of
CLS-ERG20 (F96C), excess byproduct FPP, seen as re-
leased NOH+ FOH, is increasingly detectable. This could
be caused by increased isoprene availability compared to
wild type cells and possibly increased tolerance to higher
FPP and GGPP levels. The ERAD complex plays an
important role in controlling hmgp stability and effecting
feedback inhibition from accumulating substrates. Surpris-
ingly no mutants in the ERAD pathway were identified in
the current screen. The stability of hmgp remained un-
altered, unlike in previous series of strains developed opti-
mized for sesquiterpenes. Enhanced formation of
mevalonic acid could be due to transcriptional activation
of HMGR rather than extended protein stabilization in
this case. Still, overexpression of the catalytic domain of
HMG2 provided an additional boost, a bit higher than
when HMG2 (K6R) was overexpressed, unlike the case of
previous hmgp stabilized strains, where only HMG2 (K6R)
exerted a positive effect. The excess FPP formed as side
product of the ERG20 (F96C) variant appeared in the
new strains to follow unhindered the later pathway
steps to ergosterol formation resulting in excess ste-
rols formed. In the case, of the final AM238 strain
co-expressing CLS-ERG20 (F96C), CD-HMG2 and
sclareol synthase SCLS, the total amounts of released
terpenol byproducts, which failed to be converted to
sclareol, is lower than in wild type cells, indicating
that part of the explanation is more efficient substrate
utilization towards sclareol production. Nevertheless,
the synthesis of higher amounts of squalene and er-
gosterols shows that additional improvements in sub-
strate conversion towards diterpene production can
be engineered.
Conclusion
Aiming to increase diterpenoid production in yeast,
we developed and applied an iterative yeast deletion
screening approach based on carotenoid formation.
The approach identifies series of deletions in tandem
which are compatible between them, leading to en-
hanced carotenoid formation. An additional criterion
selected for genes with minimal number of genetic
and physical interactions. This enabled the identifica-
tion of six gene deletions (rox1, dos2, yer134c, vba5,
Figure 10 Lipid droplet quantification in the engineered strains. (A) Lipid droplet accumulation in 5 days old culture of yeast visualized by Nile
red staining; (B) Overlays of flow cytometry analysis in EG60 cells (left) with empty vector (green) or expressing CLS-ERG20 (F96C) (yellow), and
AM238 cells (right) with empty vector (blue) or expressing CLS-ERG20 (F96C) (red); (C) Mean fluorescence values of strains carrying empty vector
(blue) or expressing CLS-ERG20 (F96C) (orange). 50.000 cells were counted from each strain.
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iments, while increasing 12-fold the yield of sclareol.
Such approach could be applied in various selection
schemes for which there is an easily scorable
phenotype.Methods
Chemicals and materials
Potassium hydroxide pellets, acetone (≥98%), ergosterol
(≥98%) and squalene (≥98%) used as standards and pet-
roleum ether (b.p. = 40–60°C) were all purchased from
Figure 11 Maximizing sclareol titers in AM238 cells. (A) EG60 and AM238 cells expressing CLS-ERG20 (F96C) only, CLS-ERG20 (F96C) with sclareol
synthase SCLS, and CLS-ERG20 (F96C), SCLS with CD-HMG2. The engineered iterative perturbations generated a strain producing 12-fold higher sclareol
levels than wild type cells; (B) Released NOH+ FOH and GLOH+GGOH in EG60 and AM238 cells expressing the three plasmids. A reduction of released
terpenols is seen in AM238 cells indicating a more efficient substrate conversion to sclareol; (C) Ergosterol and squalene levels in EG60 and AM238 cells
expressing the three plasmids. Ergosterol levels are reduced by half in AM238 cells co-expressing SCLS and CD-HMG2, compared to CLS-ERG20 (F96C) only.
Squalene levels are significantly increased by CD-HMG2 expression.
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from Scharlau.; Sclareol, kindly provided by VIORYL,
SA, (−)-trans-caryophyllene (Sigma, C9653-5), were
used as standard compounds; MyTaq DNA polymerase
(BIO-21105, Bioline), and Accuzyme DNA polymerase
(BIO-21051, Bioline) were used in PCR amplifications;
NucleoSpin Plasmid Kit (REF 740588.250, Macherey-
Nagel) was used for plasmid DNA purification; QIA-
quick Gel Extraction Kit (#28704, Qiagen) was used for
gel extraction and DNA purification.
Yeast media: D (+)-Glucose monohydrate (16301,
Sigma); Yeast Nitrogen Base w/o AA, carbohydrate & w/
AS (Y2025, US Biologicals); Complete Minimal (CM)
medium is composed of 0.13% (w/v) dropout powder (all
essential amino acids) [45], 0.67% (w/v) yeast nitrogenbase w/o AA, 2% glucose; TOPO TA Cloning Kit Dual
Promoter (K4610-20, Invitrogen). All yeast transforma-
tions were done by lithium acetate transformation.
Plasmids and yeast strain development
Explanations about the plasmids used can be found in
Additional file 2: Table S2. All primer sequences used
for strain development are listed in Table 3. The wild
type yeast strain EG60 was transformed with the pUG27
cassette which contains the HIS5 selection marker
flanked by loxP sites [46]. This was amplified with
primers ROX1-pUG F and ROX1-pUG R primers, which
incorporate flanking sequences complementary to the 5’
and 3’ of the ROX1 gene respectively. Proper integration
of the pUG27 cassette was verified by PCR from
Figure 12 Outline of iterative approach to identify novel
combinations of gene deletions improving carotenoid and
sclareol production.
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pUG R primers. The cassette was subsequently excised
giving rise to strain AM228. The DOS2 allele was de-
leted in AM228 cells using primers DOS2 Out pUG F
and DOS2 OutR pUGR. Proper integration of the
pUG27 cassette was verified by PCR from extractedTable 3 List of primers used
ROX1-pUG F primer ttatacat
ROX1-pUG R primer caggag
ROX1prom gctctatc
DOS2 Out pUG F gccttac





YER134c pUG F aagaga
YER134c pUG R tgacttct
YER134c prom tttcacgc
YNR063w pUG F ctgtgtc
YNR063w pUG R ctaccat
YNR063w prom ggtctat
YGR259c pUG F caggtca
YGR259c pUG R tcttaga
YGR259c prom agcgaagenomic DNA using DOS2prom and DOS2 OutR pUG
R primers. The cassette was subsequently excised giving
rise to strain AM229. The YER134c allele was deleted in
AM229 cells using primers YER134c pUG F and
YER134c pUGR. Proper integration of the pUG27 cas-
sette was verified by PCR from extracted genomic DNA
using YER134c prom and YER134c pUG R primers. The
cassette was subsequently excised giving rise to strain
AM230. The VBA5 allele was deleted in AM230 cells
using primers VBA5-pUG F and VBA5-pUGR. Proper
integration of the pUG27 cassette was verified by PCR
from extracted genomic DNA using VBA5 prom and
VBA5-pUG R primers. The cassette was subsequently
excised giving rise to strain AM231. The YNR063w allele
was deleted in AM231 cells using primers YNR063w-
pUG F and YNR063w-pUGR. Proper integration of the
pUG27 cassette was verified by PCR from extracted gen-
omic DNA using YNR063w prom and YNR063w-pUGR
primers. The cassette was subsequently excised giving
rise to strain AM233. The YGR259c allele was deleted in
AM233 cells using primers YGR259c-pUG F and
YGR259c-pUGR. Proper integration of the pUG27 cas-
sette was verified by PCR from extracted genomic DNA
using YGR259c prom and YGR259c-pUGR primers. The
cassette was subsequently excised giving rise to strain
AM238.
Construction of heterozygous deletion strains
Haploid cells MATα strains (EG60, AM228, AM229,
AM230, AM231, AM233, AM238) carrying either epi-
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sence of uracil. They were mated out with MATa
BY4741 library of deletion strains or a subset of the li-
brary and selected in glucose CM plates lacking uracil
and tryptophan.
Extraction and assay of carotenoids
Yeast cells growing on selective solid media were used
to inoculate 50 mL liquid cultures with the correspond-
ing media in 100 mL Erlenmeyer flasks which were then
incubated for 5 days at 30°C. After cultivation, cells were
collected by centrifugation (4000 rpm, 6.3 min) and the
pellet was re-suspended with 1 mL de-ionized water.
The cells were spun down (14680 rpm, 2 min) and dried
in a speedvac under full vacuum conditions (30°C, 5 h).
About 0.1 g of the dried cells was grounded, supplied
with 2 mL dimethyl sulfoxide (DMSO), incubated with
continuous vortexing at 55°C for 20 min, and finally soni-
cated for 10 min. The extracted carotenoids were col-
lected and the cells were re-extracted by repeated
vortexing with glass-beads and DMSO. A suitable amount
of acetone: hexane: 20% NaCl (1:1:1 v/v) was added to the
total supernatant extract to obtain the carotenoids into an
organic phase. The mixture was vortexed for 1 min and
centrifuged (4000 rpm, 6.3 min) to separate the two
phases. The upper phase was then transferred into an
amber glass vial and the organic solvent was evaporated
under nitrogen purge at ambient temperature. The prod-
uct was dissolved in hexane and the total carotenoid con-
tent was measured with spectrometry by recording its
absorbance at 450 nm. The concentration of the caroten-
oids was calculated in accordance to [47] and expressed as
μg/g dried cells.
Sclareol analysis
5 ml cultures in the appropriate selection media were
grown overnight at 30°C rotating in a roller drum. The
next day 500 μl of dodecane (1:10 vol.) was added to each
tube, and the cultures were incubated for two additional
days. At the end of the incubation period the organic layer
was removed into Eppendorf tubes, centrifuged to separ-
ate any residual medium left, and 200 μl were loaded on
GC vials and analyzed by GC-MS for product identifica-
tion and GC-FID for quantification.
Sterol and squalene extraction
Yeast cells growing on selective plates media were used
to inoculate 30 mL liquid cultures with the correspond-
ing media in 100 mL Erlenmeyer flasks which were then
incubated for 3 days at 30°C. After cultivation, cells were
collected by centrifugation (4000 rpm, 6.3 min) and the
pellet was re-suspended with 1 mL de-ionized water in
order to be transferred into a pre-weighted 2 mL eppen-
dorf tube. The cells were spun down (14680 rpm, 2 min)and weighted after the removal of the supernatant water.
Subsequently, the pellet was mixed with a 16 mL EtOH/
H2O 60% (v/v) mixture containing 25% KOH in a glass
tube equipped with a plastic cap and saponified at 80 ±
2°C for 2 h. Non-saponificable sterols and squalene were
extracted with 10 mL of petroleum ether, and the or-
ganic phase was collected dried under a N2 stream. The
final extract was then re-suspended in 0.5 mL acetone
and filtered through a PTFE syringe filter (0.45 μm x
25 mm) before GC analysis. For the qualitative and
quantitative analysis, stock solutions of ergosterol and
squalene in acetone were also made and calibration
curves were drawn from the prepared working solutions.
Yeast extracts were analyzed using a GC-2010 Plus Shi-
madzu gas chromatograph equipped with a flame
ionization detector, and a MEGA-5MS capillary column
(30 m x 0.25 mm, 0.25 μm film thickness), in the split-
less mode. The temperature of injector and detector was
250°C and 320°C respectively. The oven temperature
was initially held at 250°C, then increased slowly with a
rate of 2°C/min up to 300°C and maintained at this
temperature for 2 min to equilibrate. The temperature
was subsequently raised with 1°C/min at 310°C and kept
isothermally for 5 min in order to elute compounds with
higher boiling points. The carrier gas used for the ana-
lysis was helium at a flow rate of 1.3 mL/min.Flow cytometric studies
The plasmid construct pUTDH3m/HMG1-TM-EYFP
and was transformed to EG60, AM228, AM229, AM230,
AM233, AM238 and AM109, AM133 cells. Overnight
cultures of transformed cells were used to inoculate
50 ml cultures, and cells were grown to mid-log phase.
50,000 cells from each sample were measured for EYFP
fluorescence by flow cytometry using the BD FACS cali-
bur. For Nile red staining, five days old saturated cul-
tures of EG60, AM228, AM229, AM230, AM233,
AM238 cells carrying either empty vector or expressing
CLS-ERG20 (F96C) were diluted to OD600 = 1 and
stained for 10 min. with Nile red final concentration at
0.4 μg/ml. 50.000 cells were measured by flow cytome-
try, and mean fluorescence values were calculated. Over-
lay diagrams were done using the Flowing Software
version 2.5.1. (http://www.flowingsoftware.com/).Additional files
Additional file 1: Table S1. List of gene deletions selected by the
carotenoid screen.
Additional file 2: Table S2. List of plasmids used in the study.Competing interests
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